Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Pham

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Australasian Journal of Dermatology|March 10, 2026
Efficacy of Biologics for Hidradenitis Suppurativa: A Network Meta Analysis and Meta Regression for Baseline Disease SeverityJames Pham, Tara Sholji, Marra Aghajani, et al.
The Journal of Investigative Dermatology|November 15, 2024
The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical TrialAkshay Flora, James Pham, Jane A Woods, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Loss of connexin 43 in cartilage causes mitochondrial dysfunction and accelerates post-traumatic osteoarthritis progressionKristyna Hargitaiova, Rebecca M Irwin, Khizar Hayat, et al.
Dermatology (Basel, Switzerland)|July 7, 2025
Diagnostic Accuracy of a Questionnaire Screening Test in Assessing the Prevalence of Hidradenitis Suppurativa in Sydney, AustraliaJames Pham, Akshay Flora, Emily Kay Kozera, et al.
Critical Reviews in Food Science and Nutrition|November 14, 2025
(Poly)phenol metabotypes and cardiometabolic health: a systematic reviewWafa Alotaibi, Daniel Perrone, Xiaohe Liu, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytomasChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
Pharmacological Research|March 15, 2025
Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma modelsChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
ACS Central Science|November 2, 2016
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos ArylpyrrolesAlice E Williamson, Paul M Ylioja, Murray N Robertson, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Australasian Journal of Dermatology|March 10, 2026
Efficacy of Biologics for Hidradenitis Suppurativa: A Network Meta Analysis and Meta Regression for Baseline Disease SeverityJames Pham, Tara Sholji, Marra Aghajani, et al.
The Journal of Investigative Dermatology|November 15, 2024
The Clinical and Molecular Response of Pyoderma Gangrenosum to IL-23 Blockade: Result from a Proof-of-Concept Open-Label Clinical TrialAkshay Flora, James Pham, Jane A Woods, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Loss of connexin 43 in cartilage causes mitochondrial dysfunction and accelerates post-traumatic osteoarthritis progressionKristyna Hargitaiova, Rebecca M Irwin, Khizar Hayat, et al.
Dermatology (Basel, Switzerland)|July 7, 2025
Diagnostic Accuracy of a Questionnaire Screening Test in Assessing the Prevalence of Hidradenitis Suppurativa in Sydney, AustraliaJames Pham, Akshay Flora, Emily Kay Kozera, et al.
Critical Reviews in Food Science and Nutrition|November 14, 2025
(Poly)phenol metabotypes and cardiometabolic health: a systematic reviewWafa Alotaibi, Daniel Perrone, Xiaohe Liu, et al.
Biorxiv : the Preprint Server for Biology|May 3, 2023
WITHDRAWN: Dual targeting of mitochondrial Lon peptidase 1 and chymotrypsin-like protease by small molecule BT317, as potential therapeutics in malignant astrocytomasChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
Pharmacological Research|March 15, 2025
Dual targeting of the mitochondrial Lon peptidase 1 and the chymotrypsin-like proteasome activity as a potential therapeutic strategy in malignant astrocytoma modelsChristopher Douglas, Shashi Jain, Naomi Lomeli, et al.
ACS Central Science|November 2, 2016
Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos ArylpyrrolesAlice E Williamson, Paul M Ylioja, Murray N Robertson, et al.
Pageof 2